Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
HFSA 24: The HuMAIN-HFpEF Trial

Ambarish Pandey

Watch time: 4m 5s
AHA 24: The EMPEROR-Preserved Trial

Andrew JS Coats

Watch time: 4m 41s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type

Marianna Fontana

Watch time: 3m 23s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
The Evolving Treatment Landscape for HFpEF in Cardiac Amyloidosis

Watch time: 6m 18s
HFA 2026: Obesity and Natriuretic Peptides in Heart Failure — PORTHOS

Rui Baptista

Watch time: 8m 12s
DGK Berlin 2018: Die Rolle der Defibrillatorweste in der Klinischen Praxis

Lars S Maier

Watch time: 19m 28s
HFA 2019: Impact of combined multimodal approach in rehospitalisation and morbidity rate of HF patients - Dr Ilias Kanellos

Ilias Kanellos

Watch time: 2m 51s
DAPA-HF: The dapaglifozin and prevention of adverse outcomes in heart failure trial

Frank Ruschitzka

Watch time: 5m 18s
HFA 2020: Analysis from BIOSTAT-CHF

Watch time: 9m 12s
ACC 2021: Findings from the RAFT-AF Trial

Anthony SL Tang

Watch time: 15m 16s
Hypertrophic Cardiomyopathy in Review: Highlights of ACC 2022

Milind Y Desai

Watch time: 11m
CardioNerds @AHA23: ARIES HM3: Avoidance of Aspirin with LVAD Devices

Mandeep Mehra, Christian Inchaustegui

Watch time: 15m 26s
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 43m 48s
Plenary Session 1 – Multidisciplinary implementation strategies

Gerasimos Filippatos, Gianluigi Savarese, , et al

Watch time: 1h 6s